Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

67.30
Delayed Data
As of Sep 29
 0.00 / 0.00%
Today’s Change
53.45
Today|||52-Week Range
69.15
-0.52%
Year-to-Date
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
Sep 26 / TheStreet.com - Paid Partner Content
AstraZeneca Diabetes Drug Combination Positive in Phase III
Sep 19 / Zacks.com - Paid Partner Content
Here's How to Find the Best Dividend Stocks
Sep 23 / MotleyFool.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
6 Flu Season Facts You Probably Don't Know
Sep 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close67.30
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)1,364
Market cap$85.1B
Dividend yield4.14%
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)+127.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-5.32%
P/E ratio--
Price/Sales3.48
Price/Book4.60

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Chart unavailable

Search for Jobs